It is recommended that women between 30 and 65 undergo co-testing with Human papillomavirus (HPV) and Pap smear testing every five years or Pap testing alone every three years.

The bill would require most health insurance plans to cover screenings and follow up examinations for cervical cancer.

At-home health tests are booming—but are they reliable? Doctors explain which home tests are worth trying, which to skip, and ...

Women vaccinated against the human papillomavirus can safely skip many of the cervical cancer screenings that are typically recommended every three to five years, a new study from Norway suggests.

A new study shows that blood collected on a sanitary pad can be used for cervical cancer screening, opening the door to new diagnostics ...

With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and ...

For many patients, lack of insurance, limited access to providers, and other logistical hurdles stand in the way of getting ...

The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...

Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV primary screening. Hologic’s human papillomavirus (HPV) test is the only ...

Cervical cancer screenings have helped save many lives over the past 50 years. These screenings, especially those that detect HPV (human papillomavirus), are very important because HPV causes most ...

"My parents always drilled that into my head."  So, it was somewhat ironic that it was an unscheduled cancer screening that led to her doctor discovering Danielle had cervical cancer. Danielle was 29 ...